Gastrointestinal bleeding, a preventable cause of hospital admission: Time for specific studies in patients on antithrombotic therapy

Eur J Intern Med. 2023 Oct:116:38-40. doi: 10.1016/j.ejim.2023.07.033. Epub 2023 Jul 28.

Authors

Stefano Savonitto¹, Claudio Montalto², Stefano De Servi³

Affiliations

¹ Clinica San Martino, Malgrate, Italy. Electronic address: [email protected].
² De Gasperis Cardio Center, Interventional Cardiology Unit, Niguarda Hospital, Milan, Italy.
³ Department of Molecular Medicine, University of Pavia, Pavia, Italy.

PMID: 37517937
DOI: 10.1016/j.ejim.2023.07.033

No abstract available

Keywords: Anticoagulation; Antiplatelet therapy; Antithrombotic therapy; Gastrointestinal bleeding.

Publication types

Comment

MeSH terms

Anticoagulants / adverse effects
Fibrinolytic Agents* / adverse effects
Gastrointestinal Hemorrhage* / chemically induced
Gastrointestinal Hemorrhage* / prevention & control
Hospitalization
Hospitals
Humans
Platelet Aggregation Inhibitors / adverse effects
Risk Factors

Substances

Fibrinolytic Agents
Platelet Aggregation Inhibitors
Anticoagulants